These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16803511)

  • 81. DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients.
    Liu Y; Zhou ZT; He QB; Jiang WW
    Med Oncol; 2012 Jun; 29(2):729-33. PubMed ID: 21516484
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Reversion transcriptional expression of DAPK in bladder cancer T24 cells 5-aza-2'-deoxycytidine].
    Xu NR; Liu CX; Zheng SB; Li HL; Xu YW; Xu K
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1882-6. PubMed ID: 19778817
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Aberrant gene promoter methylation in sputum from individuals exposed to smoky coal emissions.
    Liu Y; Lan Q; Shen M; Jin J; Mumford J; Ren D; Keohavong P
    Anticancer Res; 2008; 28(4B):2061-6. PubMed ID: 18751376
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
    Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
    Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population.
    Ahmad ST; Arjumand W; Seth A; Saini AK; Sultana S
    Tumour Biol; 2012 Apr; 33(2):395-402. PubMed ID: 21922274
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
    Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
    PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dual promoter regulation of death-associated protein kinase gene leads to differentially silenced transcripts by methylation in cancer.
    Pulling LC; Grimes MJ; Damiani LA; Juri DE; Do K; Tellez CS; Belinsky SA
    Carcinogenesis; 2009 Dec; 30(12):2023-30. PubMed ID: 19917631
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [The Methylation of p16 Gene Promoter in Carcinogenesis and Development of Breast Cancer].
    Zhang YB; Lu HX; Zhang XR; Qin LJ; Dong GL; Sun N; Zhang T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):409-12. PubMed ID: 26121863
    [TBL] [Abstract][Full Text] [Related]  

  • 89. CDH1 promoter methylation in patients with cervical carcinoma: a systematic meta-analysis with trial sequential analysis.
    Liu G
    Future Oncol; 2018 Jan; 14(1):51-63. PubMed ID: 29237293
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.
    Jia W; Yu T; Cao X; An Q; Yang H
    Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.
    Takeuchi S; Matsushita M; Zimmermann M; Ikezoe T; Komatsu N; Seriu T; Schrappe M; Bartram CR; Koeffler HP
    Leuk Res; 2011 Oct; 35(10):1345-9. PubMed ID: 21592569
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.
    Hoffmann AC; Vallböhmer D; Prenzel K; Metzger R; Heitmann M; Neiss S; Ling F; Hölscher AH; Schneider PM; Brabender J
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1231-7. PubMed ID: 19259700
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
    Qin R; Cao L; Wang J; Liu J
    Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis.
    Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
    Arch Gynecol Obstet; 2011 Mar; 283(3):611-6. PubMed ID: 20405295
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population.
    Rizvi MM; Alam MS; Ali A; Mehdi SJ; Batra S; Mandal AK
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1255-62. PubMed ID: 21698421
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Alterations of the P16 gene in uterine cervical carcinoma from Indian patients.
    Tripathi A; Banerjee S; Roy A; Roychowdhury S; Panda CK
    Int J Gynecol Cancer; 2003; 13(4):472-9. PubMed ID: 12911724
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue.
    Celebiler Cavusoglu A; Sevinc AI; Saydam S; Canda T; Baskan Z; Kilic Y; Sakizli M
    Neoplasma; 2010; 57(5):465-72. PubMed ID: 20568901
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Methylation of death-associated protein kinase in ovarian carcinomas.
    Collins Y; Dicioccio R; Keitz B; Lele S; Odunsi K
    Int J Gynecol Cancer; 2006; 16 Suppl 1():195-9. PubMed ID: 16515590
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In epithelial cancers, aberrant
    Thangavelu PU; Krenács T; Dray E; Duijf PH
    Clin Epigenetics; 2016; 8():120. PubMed ID: 27891193
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Tumor-suppressor gene SOX1 is a methylation-specific expression gene in cervical adenocarcinoma.
    Yuan M; Yao L; Abulizi G
    Medicine (Baltimore); 2019 Sep; 98(38):e17225. PubMed ID: 31567982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.